Wellcome Research Laboratories other research news

The Kent, U.K., research lab published in Nature the properties of molecules that can serve as co-stimulators of CD4 T lymphocytes.

The molecules enhance CD4 Th cell priming and CD8 cytotoxic T cell priming to viral antigens. Tucaresol is an orally active member of this class of molecules that Wellcome had tested in animals for other applications when the immune stimulation was noticed. ...